UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Structural mechanisms of DREAM complex assembly and regulation

Genes & development, 2015-05, Vol.29 (9), p.961-974

2015

Volltextzugriff (PDF)

Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family

Journal of molecular biology, 2016-10, Vol.428 (20), p.3960-3971

2016

Volltextzugriff (PDF)

Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of binding

Structure (London), 2023-01, Vol.31 (1), p.20-32.e5

2023

Volltextzugriff (PDF)

Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family

Proceedings of the National Academy of Sciences - PNAS, 2017-05, Vol.114 (19), p.4942-4947

2017

Volltextzugriff (PDF)

A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody

Scientific reports, 2024-05, Vol.14 (1), p.10661-10661, Article 10661

2024

Volltextzugriff (PDF)

Multiple Mechanisms for E2F Binding Inhibition by Phosphorylation of the Retinoblastoma Protein C-Terminal Domain

Journal of molecular biology, 2014-01, Vol.426 (1), p.245-255

2014

Volltextzugriff (PDF)

Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization

PLoS pathogens, 2021-09, Vol.17 (9), p.e1009543-e1009543

2021

Volltextzugriff (PDF)

Abstract 6368: Preclinical pharmacology and safety studies of ZG005: an anti-PD-1/TIGIT bispecific mAb in a phase I clinical trial for advanced tumors

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6368-6368

2023

Volltextzugriff (PDF)

Abstract 2323: ZGGS18, a bispecific drug candidate of anti-VEGF and TGFbeta-trap, inhibiting tumor proliferation and improving tumor microenvironment with I/O therapy

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2323-2323

2023

Volltextzugriff (PDF)

Identification of the SSB binding site of Uracil DNA Glycosylase

The FASEB journal, 2010-04, Vol.24 (S1), p.lb49-lb49

2010

Volltextzugriff (PDF)

Multiple Mechanisms for E2F Binding Inhibitionby Phosphorylation of the Retinoblastoma Protein C-terminal Domain

Journal of molecular biology, 2013-10, Vol.426 (1)

2013

Volltextzugriff (PDF)

Structural conservation and E2F binding specificity within the retinoblastoma pocket protein family

Liban, Tyler James

2016

Volltextzugriff (PDF)

Using the Thickness of Graphene to Template Lateral Subnanometer Gaps between Gold Nanostructures

Nano letters, 2015-01, Vol.15 (1), p.635-640

2015

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(13)
Dissertationen
(1)

Sprache

Englisch
(14)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Structural mechanisms of DREAM complex assembly and regulation

Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family

Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of binding

Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family

A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody

Multiple Mechanisms for E2F Binding Inhibition by Phosphorylation of the Retinoblastoma Protein C-Terminal Domain

Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization

Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability

Abstract 6368: Preclinical pharmacology and safety studies of ZG005: an anti-PD-1/TIGIT bispecific mAb in a phase I clinical trial for advanced tumors

Abstract 2323: ZGGS18, a bispecific drug candidate of anti-VEGF and TGFbeta-trap, inhibiting tumor proliferation and improving tumor microenvironment with I/O therapy

Identification of the SSB binding site of Uracil DNA Glycosylase

Multiple Mechanisms for E2F Binding Inhibitionby Phosphorylation of the Retinoblastoma Protein C-terminal Domain

Structural conservation and E2F binding specificity within the retinoblastoma pocket protein family

Using the Thickness of Graphene to Template Lateral Subnanometer Gaps between Gold Nanostructures

Suchergebnisse filtern